echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Nature: Scientists discover key protein that inhibits pancreatic cancer metastasis

    Nature: Scientists discover key protein that inhibits pancreatic cancer metastasis

    • Last Update: 2022-09-06
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Pancreatic ductal adenocarcinoma (PDAC) is an insidious onset and a malignancy with a poor prognosis, with a five-year survival rate of less than 7%, and is characterized by prominent genomic aberrations and increased glycolytic phenotypes


    Recently, a joint research team from the Sutton Cancer Institute in the United Kingdom and Imperial College London discovered a protein (GREM1) that plays a key role in the growth and metastasis of pancreatic cancer


    Paper link:

    #additional-information

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.